Brain fuel mystery: Glucagon's role in thinking and sugar
NCT ID NCT06921824
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study looked at how the hormone glucagon affects brain function and sugar use in 16 healthy adults. Participants received a gradually increasing dose of glucagon through an IV over three hours. The goal was to find the dose that changes blood sugar and other markers, helping researchers understand glucagon's role in the brain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Glucagon
What this could lead to
If successful, this could help scientists understand how glucagon affects the brain and sugar use, possibly pointing toward new treatments for metabolic or cognitive disorders.
What could go wrong
This is a very small, early pilot study in healthy people, not patients. It only looks at short-term effects, so results may not apply to real-world conditions or lead to any treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLUCOSE METABOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark
Copenhagen, 2400, Denmark